The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype

Clive S. Zent(University of Rochester Medical Center), John D. Shaughnessy(University of Arkansas for Medical Sciences), Fenghuang Zhan(Winthrop Rockefeller Foundation), Steven A. Schichman(Central Arkansas Veterans Healthcare System), Pei Lin(The University of Texas MD Anderson Cancer Center), James B. Chen(University of Arkansas for Medical Sciences), Klaus Bumm(Texas Tech University)
Leukemia Research
March 25, 2003
10.1016/s0145-2126(03)00015-8
Cited by 28

Related Papers

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
|Cell Reports|2018|1.1k
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
|Cancer Cell|2018|980
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
|Cell Systems|2018|959
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949